Table 4 Overall survival data for patients stratified according to C30 and HCC18 index score range (n = 472)
N | Median OS (M) | 95% CI | Survival% at 6M | Survival% at 12M | Survival% at 24M | Survival% at 36M | |
|---|---|---|---|---|---|---|---|
C30 Index Score | |||||||
0–20 | 179 | 16.4 | 13.4–22.3 | 79.7 | 60.4 | 41.3 | 25.6 |
21–40 | 153 | 7.3 | 4.5–10.4 | 52.0 | 39.2 | 26.0 | 21.4 |
41–60 | 98 | 3.1 | 2.3–5.1 | 36.5 | 27.0 | 18.3 | 8.1 |
61–80 | 34 | 1.8 | 0.8–4.3 | 27.5 | 10.7 | 7.1 | 7.1 |
81–100 | 8 | 1.8 | 0.5–6.0 | 25.0 | - | - | - |
HCC18 Index Score | |||||||
0–20 | 213 | 16.4 | 31.0-NR | 74.6 | 59.9 | 43.1 | 27.8 |
21–40 | 169 | 6.0 | 4.4–8.9 | 49.6 | 33.1 | 19.3 | 14.5 |
41–60 | 72 | 2.8 | 1.6–4.3 | 31.1 | 16.7 | 11.8 | 5.3 |
61–80 | 16 | 1.8 | 0.5–3.0 | 25.0 | 18.8 | 9.4 | - |
81–100 | 2 | 1.8 | 0.7–2.9 | - | - | - | - |